Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
17 November 2015 |
Main ID: |
NCT02591264 |
Date of registration:
|
28/10/2015 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Periprocedural Myocardial Infarction: the Role of Human Neutrophil Peptide-1 to 3
|
Scientific title:
|
|
Date of first enrolment:
|
November 2015 |
Target sample size:
|
120 |
Recruitment status: |
Not yet recruiting |
URL:
|
https://clinicaltrials.gov/show/NCT02591264 |
Study type:
|
Observational |
Study design:
|
Observational Model: Case Control, Time Perspective: Prospective
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Israel
| | | | | | | |
Contacts
|
Name:
|
Rami Abu Fanne, MD, PhD |
Address:
|
|
Telephone:
|
972-50-3573694 |
Email:
|
ramia@hadassah.org.il |
Affiliation:
|
|
|
Name:
|
Rami Abu Fanne, MD, PhD |
Address:
|
|
Telephone:
|
972-50-3573694 |
Email:
|
ramia@hadassah.org.il |
Affiliation:
|
|
| |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Troponin negative patients
- Stable angina
- Unstable angina
- Positive screening tests
Exclusion Criteria:
- Troponin positive
- Technical failure of procedure
- Hemodynamic unstability
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Coronary Thrombosis
|
Intervention(s)
|
Other: Blood sample
|
Primary Outcome(s)
|
Human Neutrophil Peptide Level
[Time Frame: Two hours]
|
Secondary ID(s)
|
90-14-HYMC
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|